FTC Takes Bold Stand: Major PBMs Face Scrutiny Over Inflated Insulin Prices!
WASHINGTON, D.C. — In a move to address escalating insulin prices, the Federal Trade Commission (FTC) has initiated action against the three largest prescription drug benefit managers (PBMs) in the …
FTC Takes Bold Stand: Major PBMs Face Scrutiny Over Inflated Insulin Prices! Read More